Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Clinical trial NCT04590963 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04590963
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2020-10-02
Primary completion: 2022-05-11
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.